Megan Bergeron
Psychiatry · Houma, LANPI 1649850124
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,666, 2.5 times the $655 reported in 2021.
Across 184 payments — averaging $24.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$806
- Neurocrine Biosciences, Inc.$614
- Alkermes, Inc.$561
- Axsome Therapeutics, Inc.$363
- Otsuka America Pharmaceutical, Inc.$349
- Vanda Pharmaceuticals Inc.$287
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $806 |
| Neurocrine Biosciences, Inc. | 19 | $614 |
| Alkermes, Inc. | 27 | $561 |
| Axsome Therapeutics, Inc. | 11 | $363 |
| Otsuka America Pharmaceutical, Inc. | 14 | $349 |
| Vanda Pharmaceuticals Inc. | 9 | $287 |
| Teva Pharmaceuticals USA, Inc. | 8 | $237 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $224 |
| Johnson & Johnson | 4 | $202 |
| Merck | 8 | $161 |
| E.r. Squibb & Sons, L.L.C. | 11 | $149 |
| Corium, LLC | 8 | $85 |
| Lundbeck LLC | 5 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Sunovion Pharmaceuticals Inc. | 3 | $45 |
| Dexcom, Inc. | 2 | $42 |
| Cardiva Medical, Inc. | 2 | $36 |
| Indivior Inc. | 2 | $31 |
| Exact Sciences | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Braeburn Inc. | 1 | $16 |
| Biocryst US Sales Co., LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,444 in reported general payments places this provider in the 85th percentile of 474 psychiatry providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $89,263 |
| VraylarCariprazine Hcl | 18 | $25,263 |
| AuvelityDextromethorphan Hbr/Bupropion | 17 | $20,652 |
| Lurasidone Hcl | 22 | $3,126 |
| Clonazepam | 73 | $1,118 |
| Doxepin Hcl | 17 | $940 |
| Buspirone Hcl | 57 | $761 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 19 | $690 |
| Quetiapine Fumarate | 63 | $669 |
| Trazodone Hcl | 64 | $559 |
| Oxcarbazepine | 19 | $478 |
| Olanzapine | 41 | $351 |
| Aripiprazole | 13 | $281 |
| Duloxetine Hcl | 17 | $265 |
| Ziprasidone Hcl | 15 | $256 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $614 | $89,26311 claims |
| AbbVieVraylar | $806 | $25,26318 claims |
| Axsome Therapeutics, Inc.Auvelity | $363 | $20,65217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 474 psychiatry providers in Louisiana.
Other psychiatry in Houma
- Nicolas VergaraHouma$5K
- Patrick HayesLake Charles$837K
- Maria CruseThibodaux$522K
- Larry WarnerBaton Rouge$495K
- Gregory BrownShreveport$495K
- Arwen PodestaNew Orleans$466K
- Jasjit SinghShreveport$420K
- Roger BrownMandeville$216K
- Abdul KhanBaton Rouge$156K
- William ColombMandeville$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.